Clincosm LogoSign in Get a demo

neoplasms by site

Showing 1 - 25 of 59
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lung Cancer, Multiple Pulmonary Nodules, Lung Tumors Trial in Orlando, Rochester, Pinehurst (Ion Endoluminal System)

Not yet recruiting
  • Lung Cancer
  • +8 more
  • Ion Endoluminal System
  • Orlando, Florida
  • +2 more
Aug 16, 2023

Pancreas Tumor, Stomach Tumor, Gastrointestinal Tumors Trial (EO-3021)

Not yet recruiting
  • Pancreas Neoplasm
  • +5 more
  • (no location specified)
Jul 31, 2023

ccRCC, Clear Cell Renal Cell Carcinoma, Kidney Cancer Trial (NKT2152, palbociclib, sasanlimab)

Not yet recruiting
  • ccRCC
  • +20 more
  • (no location specified)
Jul 6, 2023

Tumors, Hematologic Tumors, Tumors by Site Trial in Wuhan (RD13-02 cell infusion)

Recruiting
  • Neoplasms
  • +3 more
  • RD13-02 cell infusion
  • Wuhan, Hubei, China
    Union Hospital, Huazhong University of Science and Technology
Jun 8, 2023

Solid Tumor, Haematological Malignancy, Malignant Tumor Trial in United Kingdom (Alectinib)

Recruiting
  • Solid Tumor
  • +10 more
  • Belfast, United Kingdom
  • +25 more
Mar 14, 2023

Solid Tumor, Haematological Malignancy, Malignancy Trial in United Kingdom (Entrectinib)

Recruiting
  • Solid Tumor
  • +10 more
  • Belfast, United Kingdom
  • +25 more
Mar 14, 2023

Malignancy, Malignant Tumor, Lymphoproliferative Disorders Trial in United Kingdom (Atezolizumab)

Not yet recruiting
  • Malignancy
  • +8 more
  • Belfast, United Kingdom
  • +25 more
Mar 14, 2023

Tumors, Hematologic Tumors, Tumors by Site Trial in Hangzhou (RD13-02 cell infusion)

Recruiting
  • Neoplasms
  • +3 more
  • RD13-02 cell infusion
  • Hangzhou, Zhejiang, China
    The first affiliated hospital of medical college of zhejiang uni
Feb 6, 2023

NSCLC, NSCLC, Carcinoma, Bronchogenic Trial in Worldwide (Furmonertinib)

Recruiting
  • Non-Small Cell Lung Cancer
  • +14 more
  • Glendale, California
  • +12 more
Feb 2, 2023

Breast Tumors, Brain Tumors, Tumors by Site Trial (Abemaciclib, Elacestrant)

Recruiting
  • Breast Neoplasms
  • +7 more
  • Canton, Ohio
    Gabrail Cancer Center
Jan 24, 2023

Carcinoma, Carcinoma, Renal Cell, Kidney Tumors Trial in Worldwide (Savolitinib, Sunitinib)

Active, not recruiting
Has Results
  • Carcinoma
  • +7 more
  • La Jolla, California
  • +58 more
Jan 13, 2023

Tumors by Site Trial in Worldwide (nivolumab, rHuPH20)

Active, not recruiting
  • Neoplasms by Site
  • Atlanta, Georgia
  • +35 more
Jan 6, 2023

NSCLC, NSCLC, Carcinoma, Bronchogenic Trial in United States (furmonertinib 240 mg, furmonertinib 160 mg, platinum-based chemo)

Recruiting
  • Non-Small Cell Lung Cancer
  • +13 more
  • furmonertinib 240 mg
  • +2 more
  • Yuma, Arizona
  • +37 more
Dec 14, 2022

Prostatic Tumors, Castration-Resistant, Tumors by Histologic Type, Tumors, Prostate Trial in United States (P-PSMA-101 CAR-T

Active, not recruiting
  • Prostatic Neoplasms, Castration-Resistant
  • +16 more
  • Duarte, California
  • +9 more
Nov 15, 2022

RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Worldwide

Active, not recruiting
  • RET-altered Non Small Cell Lung Cancer
  • +39 more
  • pralsetinib (BLU-667)
  • Phoenix, Arizona
  • +65 more
Nov 10, 2022

Stomach Tumors, Digestive System Tumors, Tumors Trial in Fuzhou (Camrelizumab, SOX, Surgery)

Active, not recruiting
  • Stomach Neoplasms
  • +5 more
  • Fuzhou, Fujian, China
    The Second Affiliated Hospital of Fujian Medical University
Nov 1, 2022

Lung Tumors, NSCLC, Respiratory Tract Tumors Trial in Worldwide (BLU-945, osimertinib)

Recruiting
  • Lung Neoplasms
  • +23 more
  • La Jolla, California
  • +35 more
Oct 6, 2022

Uterine Cervical Tumor, Uterine Tumors, Genital Tumors, Female Trial in Seattle (Usual Care, Education, Direct Mail)

Active, not recruiting
  • Uterine Cervical Neoplasm
  • +13 more
  • Usual Care
  • +3 more
  • Seattle, Washington
    Kaiser Permanente Washington Health Research Institute
Aug 16, 2022

Tumors, Colorectal Tumors, Melanoma Trial in United States (Alectinib)

Terminated
  • Neoplasms
  • +27 more
  • Culver City, California
  • +28 more
Jul 25, 2022

Colorectal Cancer, RAS and BRAF Wild-type, Colorectal Tumors Trial in Hangzhou (Anlotinib Hydrochloride, Capecitabine,

Completed
  • Colorectal Cancer
  • +12 more
  • Anlotinib Hydrochloride
  • +2 more
  • Hangzhou, Zhejiang, China
  • +1 more
Jul 12, 2022

Lung Tumor, NSCLC, Respiratory Tract Tumors Trial in United States (BLU-701, osimertinib, carboplatin)

Recruiting
  • Lung Neoplasm
  • +26 more
  • Boston, Massachusetts
  • +6 more
Jun 23, 2022

Cervical Cancer, Uterine Cervical Tumor, Uterine Tumors Trial in Sweden (Sending of screening summon.)

Recruiting
  • Cervical Cancer
  • +9 more
  • Sending of screening summon.
  • Lund, Skåne, Sweden
  • +5 more
Apr 21, 2022

Pancreatic Tumor, Digestive System Tumor, Tumors by Site Trial

Not yet recruiting
  • Pancreatic Neoplasm
  • +7 more
    • (no location specified)
    Apr 19, 2022

    Palliative Primary Tumor Resection in Minimally Symptomatic

    Recruiting
    • Colorectal Neoplasms
    • +12 more
    • Moscow, Russian Federation
      Ryzhikh National Medical Research Center of Coloproctology
    Apr 2, 2022

    Lung Tumor Malignant, NSCLC, Respiratory Tract Tumors Trial in United States (BLU-451)

    Recruiting
    • Lung Neoplasm Malignant
    • +18 more
    • Fairfax, Virginia
      New Experimental Therapeutics of Virginia (NEXT Oncology)
    Mar 29, 2022